DNA Methylation and Bladder Cancer: Where Genotype does not Predict Phenotype

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• The link between Bladder cancer (BC) and DNA methylation was first observed nearly 30 years ago.
• Recent research has deepened the understanding of the mechanisms connecting BC and DNA methylation.
• However, the clinical utility of DNA methylation markers for BC remains limited.

Purpose of the Study:

• To critically discuss the mediocre performance of current DNA methylation markers in clinical settings for Bladder cancer.
• To address the need for understanding inter-individual methylation variations in BC.
• To explore the knowledge gaps regarding methylation fingerprints in distinct histological subtypes of BC.

Main Methods:

• Review of existing literature on DNA methylation and Bladder cancer.
• Analysis of factors contributing to methylation marker performance.
• Discussion of methylation patterns in different BC subtypes.

Main Results:

• Significant advancements in understanding the BC-DNA methylation connection.
• Persistent challenges with the clinical applicability of DNA methylation markers.
• Identification of critical knowledge gaps concerning methylation variations and subtype specificity.

Conclusions:

• The clinical performance of DNA methylation markers in Bladder cancer requires significant improvement.
• Further investigation into inter-individual variations and subtype-specific methylation is crucial.
• Future research should focus on elucidating the cascade of epigenetic events driving cancer-specific methylation patterns.